{"id":"W2473498748","doi":"10.1200/jco.2016.67.3467","title":"Programmed Death-1 Blockade With Pembrolizumab in Patients With Classical Hodgkin Lymphoma After Brentuximab Vedotin Failure","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":672,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; American Society of Clinical Oncology","keywords":"Medicine; Brentuximab vedotin; Pembrolizumab; Internal medicine; Oncology; Cohort; Adverse effect; Lymphoma; Gastroenterology; Cancer; Immunotherapy; Hodgkin lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008559345,0.0002873703,0.0007128236,0.0002194561,0.0003117827,0.0003789933,0.0002088524,0.0002868719,0.000425011],"category_scores_gemma":[0.001103557,0.0001300157,0.0002901664,0.0002205237,0.0002842205,0.0003379134,0.000232634,0.0004793094,0.0001165765],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004401342,"about_ca_system_score_gemma":0.0003479338,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004848517,"about_ca_topic_score_gemma":0.001300672,"domain_scores_codex":[0.9996877,0.0001091838,0.00003963201,0.00004993817,0.00004944123,0.00006403444],"domain_scores_gemma":[0.9995176,0.0001340071,0.0001107463,0.00002225792,0.00002865282,0.0001868835],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.04375237,0.002128537,0.6796609,0.0006190751,0.000710177,0.01047555,0.0006281882,0.002224317,0.03539642,0.0004023837,0.002580334,0.2214218],"study_design_scores_gemma":[0.006669458,0.06019553,0.8962182,0.00018331,0.0005767503,0.01605521,0.0003404581,0.005516424,0.007193088,0.0005444603,0.006454737,0.00005236016],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966254,0.002267143,0.0002222924,0.0001378498,0.00001994281,0.00006479001,0.00005472885,0.00001574993,0.0005919641],"genre_scores_gemma":[0.9992408,0.0002589083,0.0001325412,0.0001636601,0.00002426261,0.00001968387,0.00007141822,0.000001137832,0.00008769659],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0008559345,"threshold_uncertainty_score":0.004526675,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03249842587650171,"score_gpt":0.355362388881699,"score_spread":0.3228639630051973,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}